Nagalingeswaran Kumarasamy

Dr N Kumarasamy is the Chief & Director of Infectious Diseases Medical Centre  at Voluntary Health Services (VHS) Hospital in Chennai and directs the clinic which provides medical care for persons with HIV, Hepatitis, Tuberculosis, COVID19 and other Infectious Diseases in Chennai, Southern India. 

Dr Kumarasamy is the Director of the Chennai Antiviral Research and Treatment (CART) Clinical Research Site which conducts multisite Therapeutics and prevention clinical trials in HIV and other Infectious Diseases. He is involved as Clinical Investigator for several on- going clinical research projects with University of California-San Diego, Brown University- Providence , Harvard University-Boston, USA and University of New South Wales/Kirby Institute -Sydney, Australia.  

Dr Kumarasamy is a clinician and a researcher in Infectious disease with more than 25 yrs of experience and has published more than 400 manuscripts in peer reviewed medical journals. He has conducted several landmark Antiretroviral clinical trials which had impacted Treatment Guidelines. His publications on Impact of Antiretroviral therapy has led to several Antiretroviral scale up programs in developing countries. Dr Kumarasamy is an advisor and expert panel member for World Health Organization – ARV Treatment guidelines committee and a Clinical advisor to Clinton Health Access Initiative. He has a particular interest on the long term impact of Antiretroviral Therapy in resource limited settings. 

Dr Kumarasamy is the Head of Department of VHS COVID19 Treatment and Vaccination Centre. His department had managed more than 6500 persons with COVID. He is a lead investigator in several COVID Treatment trials involving antivirals, monoclonal antibody and anti-inflammatory drugs in collaboration with WHO, NIH and ICMR.  He is serving as a member of COVID19 National Task Force for Clinical Research and Drug Development.  

A full list of published work is available here